For the year ending 2026-01-03, HLIO had $28.9M increase in cash & cash equivalents over the period. $103.6M in free cash flow.
| Cash Flow | 2026-01-03 |
|---|---|
| Net income | 48.4 |
| Depreciation and amortization | 63 |
| (gain) on sale of business | 18.8 |
| Goodwill impairment | 25.9 |
| Stock-based compensation expense | 5.1 |
| Amortization of debt issuance costs | 0.7 |
| Benefit for deferred income taxes | -1.1 |
| Forward contract losses, net | -0.6 |
| Other, net | 5.3 |
| Accounts receivable | 16.5 |
| Inventories | 2.7 |
| Income taxes receivable | -0.3 |
| Other current assets | -4.2 |
| Other assets | -4.7 |
| Accounts payable | 22 |
| Accrued expenses and other liabilities | 2.1 |
| Income taxes payable | -0.7 |
| Other noncurrent liabilities | -4.6 |
| Contingent consideration payments in excess of acquisition date fair value | 0 |
| Net cash provided by operating activities | 127.3 |
| Business acquisitions, net of cash acquired | 0 |
| Capital expenditures | 23.7 |
| Proceeds from dispositions of property, plant and equipment | 0.3 |
| Business divestiture proceeds | 47.3 |
| Cash settlement of forward contracts | 0 |
| Software development costs | -3.6 |
| Net cash provided by (used in) investing activities | 20.3 |
| Borrowings on revolving credit facilities | 57.6 |
| Repayment of borrowings on revolving credit facilities | 114.3 |
| Borrowings on long-term non-revolving debt | 0 |
| Repayment of borrowings on long-term non-revolving debt | 38.2 |
| Proceeds from stock issued | 1.8 |
| Purchase of treasury stock | 13.6 |
| Dividends paid to shareholders | 12 |
| Payment of employee tax withholding on equity award vestings | 1.4 |
| Payment of contingent consideration liability | 0 |
| Proceeds received upon termination of cash flow hedge instruments | 0 |
| Other financing activities | -1.8 |
| Net cash (used in) provided by financing activities | -121.9 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 3.2 |
| Net increase (decrease) in cash and cash equivalents | 28.9 |
| Cash, cash equivalents and restricted cash, beginning of period | 44.1 |
| Cash, cash equivalents and restricted cash, end of period | 73 |
HELIOS TECHNOLOGIES, INC. (HLIO)
HELIOS TECHNOLOGIES, INC. (HLIO)